Wire Stories
China NMPA Approves Bio-Thera Solutions� BAT1806, A Biosimilar to Actemra� (Tocilizumab)
World�s First Approved Biosimilar to Actemra� GUANGZHOU, China–(BUSINESS WIRE)–#Actemra–Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage biopharmaceutical company, announced that the China National...